How to Test Your hs-CRP Levels (and What the Results Mean)

How to Test Your hs-CRP Levels (and What the Results Mean)

Yes, hs-CRP is a simple fasting blood draw available at virtually any commercial lab — no specialist referral required in most states. The main caveat is that one elevated result means almost nothing on its own; acute illness, injury, or even vigorous exercise in the 48 hours before your draw can artificially spike the reading. The exception is people with known autoimmune disease, for whom the result should always be interpreted alongside other inflammatory markers and their physician's guidance.

---

What Is hs-CRP and Why Does It Differ from Standard CRP?

C-reactive protein (CRP) is a protein the liver releases in response to inflammation-signaling cytokines, primarily interleukin-6. The standard CRP test was designed to detect acute infection or tissue injury — it reliably catches values above 10 mg/L. High-sensitivity CRP, or hs-CRP, uses a more precise immunoturbidimetric or nephelometric assay that can accurately measure values between 0.1 mg/L and 10 mg/L. That lower detection range is exactly where chronic, low-grade vascular and metabolic inflammation lives.

The clinical importance of this distinction is not trivial. The JUPITER trial, which enrolled 17,802 apparently healthy adults with LDL below 130 mg/dL, found that participants with hs-CRP ≥ 2.0 mg/L had significantly elevated cardiovascular event rates — and that statin therapy reduced both hs-CRP and major cardiovascular events in that group (Ridker et al., New England Journal of Medicine 2008; PMID: 18997196). In other words, hs-CRP was capturing risk that the lipid panel was missing entirely.

hs-CRP has also emerged as a useful metabolic marker. Elevated levels correlate strongly with insulin resistance, visceral adiposity, and non-alcoholic fatty liver disease — making it relevant not just for cardiologists but for anyone tracking metabolic health. If you've ever had your blood test results explained in a standard annual panel and wondered why the inflammation piece was missing, hs-CRP is the marker that fills that gap.

---

How to Order an hs-CRP Test

Getting tested is straightforward. You have four main pathways:

1. Ask your primary care physician. Most PCPs will order hs-CRP as part of a cardiovascular risk workup, especially if you have risk factors like hypertension, family history of early heart disease, or prediabetes. Use CPT code 86141 if you need to reference it.
2. Order through a direct-access lab. Quest Diagnostics, LabCorp, and several regional labs allow consumer-ordered hs-CRP tests without a physician order in most U.S. states. Typical cost runs $15–$40 out of pocket.
3. Use a comprehensive health platform. Services like Function Health bundle hs-CRP into full panel testing alongside 100+ markers. This is useful for seeing your hs-CRP in context of other metabolic and cardiometabolic markers.
4. Include it in personalized health monitoring. Ones analyzes uploaded lab results including hs-CRP as part of its AI-driven health assessment, which is why having the test done before building a supplement formula is valuable — the number informs which anti-inflammatory or system-support ingredients belong in your capsule plan.

Pre-Test Instructions

hs-CRP does not strictly require fasting, but fasting for 8–12 hours before your draw is recommended by most cardiologists for consistency across serial measurements. More critically:

• Avoid vigorous exercise 48 hours before the draw. Intense resistance or endurance training transiently raises CRP for 24–48 hours.
• Postpone if you are acutely ill. A cold, flu, dental procedure, or any active infection will spike your reading and make the result uninterpretable for cardiovascular risk purposes.
• Disclose medications. NSAIDs and statins lower CRP; failure to disclose can lead to a falsely reassuring baseline.

If your result comes back elevated and you weren't acutely ill, most guidelines recommend repeating the test two to four weeks later. The American Heart Association uses the average of two readings taken at least two weeks apart for cardiovascular risk stratification (Pearson et al., Circulation 2003; PMID: 12551878).

---

hs-CRP Reference Ranges and Optimal Targets

Understanding what your number actually means requires knowing which reference frame your lab is using. Here are the standard AHA/CDC risk categories alongside what integrative and functional medicine practitioners typically target:

It's worth noting that values above 10 mg/L exit the hs-CRP's intended use case and move into territory better evaluated by a standard CRP test alongside a complete metabolic workup. Most labs will flag a result > 10 mg/L with a note advising clinical correlation.

For cardiovascular risk purposes, the goal most preventive cardiologists aim for is < 1.0 mg/L, with < 0.5 mg/L considered optimal in people at elevated baseline risk. A landmark meta-analysis of 54 prospective studies involving 160,309 participants confirmed a log-linear relationship between hs-CRP and coronary heart disease risk that persisted after adjustment for traditional risk factors (Kaptoge et al., Lancet 2010; PMID: 20031199).

---

What Drives hs-CRP Up? Key Metabolic and Lifestyle Factors

hs-CRP doesn't rise in a vacuum. Understanding the drivers helps you interpret the result and design a real intervention rather than just watching the number.

Insulin resistance and visceral fat are among the most potent drivers of chronic low-grade inflammation. Adipose tissue — particularly visceral fat — secretes pro-inflammatory adipokines that trigger hepatic CRP production. This is one reason why hs-CRP tracks so closely with insulin resistance. If you're also looking at your metabolic picture, pairing your hs-CRP with a HOMA-IR calculation gives you a much clearer picture of how much metabolic inflammation is contributing. The HOMA-IR blood test (derived from fasting glucose and fasting insulin) is not the same as a separate test, but it's worth understanding both markers together — insulin resistance and elevated hs-CRP form a self-reinforcing cycle that accelerates atherosclerosis.

Sleep disruption is another powerful inflammatory signal. Short sleep duration (< 6 hours) and poor sleep architecture consistently associate with elevated hs-CRP in epidemiological studies. Chronic stress through the HPA axis elevates cortisol variably, and paradoxically, sustained hypercortisolism can blunt the normal anti-inflammatory action of cortisol, allowing IL-6 and CRP to drift upward. If you're also tracking cortisol, reviewing the differences between cortisol testing methods can help you determine whether the adrenal axis is contributing to your inflammatory load.

Dietary patterns matter considerably. Ultra-processed food consumption, high refined carbohydrate intake, and low omega-3 fatty acid status all independently elevate hs-CRP. A large trial showed that Mediterranean diet adherence reduced hs-CRP by roughly 20% over 12 months compared to a low-fat control diet (Estruch et al., Annals of Internal Medicine 2006; PMID: 16418406).

Periodontal disease, gut dysbiosis, and subclinical infections are less obvious but clinically meaningful. The gut-liver axis means that a leaky or dysbiotic gut can chronically stimulate hepatic CRP production through bacterial lipopolysaccharide translocation.

---

ApoB and Omega-3 Index: Which Other Tests Complement hs-CRP?

hs-CRP is most powerful when read alongside other markers that capture different dimensions of cardiovascular risk. Two tests deserve particular attention here.

ApoB (Apolipoprotein B): Every atherogenic lipoprotein particle — LDL, VLDL, IDL, Lp(a) — carries exactly one ApoB molecule. This makes ApoB a direct particle count, and several major cardiovascular societies now consider it superior to LDL-C for predicting atherosclerotic risk, particularly in people with metabolic syndrome or triglycerides above 150 mg/dL. When hs-CRP is elevated alongside a high ApoB, the combination signals both a high particle burden and an inflammatory environment that accelerates plaque vulnerability — a particularly high-risk phenotype. Conversely, an elevated hs-CRP with a low ApoB might direct attention more toward metabolic or autoimmune inflammation than toward classical atherosclerosis.

Omega-3 Index: This whole-blood test measures EPA + DHA as a percentage of total red blood cell fatty acids. A low omega-3 index (< 4%) is an independent predictor of cardiovascular events, and omega-3 fatty acids are among the best-studied natural modulators of hs-CRP. The Omega-3 Index test is particularly worth ordering if your hs-CRP is in the 1–3 mg/L range without an obvious explanation — low EPA/DHA status is both a driver of that reading and a directly actionable finding.

C-peptide, which reflects pancreatic beta-cell insulin secretory capacity, adds further context in metabolic cases. An elevated hs-CRP with a simultaneously elevated C-peptide points toward a hyperinsulinemic, insulin-resistant inflammatory state rather than a purely vascular one. This distinction matters because the interventions differ: the insulin-resistant phenotype responds strongly to dietary carbohydrate reduction, resistance training, and sleep optimization, while the vascular-inflammatory phenotype may require more direct lipid and inflammatory management.

---

How to Lower hs-CRP: Evidence-Based Interventions

Once you have a confirmed elevated hs-CRP on two readings, intervention should be systematic. Here is a priority-ranked approach supported by clinical evidence:

1. Address root metabolic drivers first. If HOMA-IR or fasting insulin is elevated, prioritize carbohydrate quality, caloric balance, and resistance training. Even a 5–10% reduction in body weight reduces hs-CRP significantly in overweight adults.
2. Optimize omega-3 status. Meta-analyses of EPA/DHA supplementation consistently show reductions in hs-CRP, particularly at doses of 2–4 g/day of combined EPA+DHA. The effect is most pronounced in people with baseline hs-CRP > 2.0 mg/L.
3. Adopt a Mediterranean or anti-inflammatory dietary pattern. The PREDIMED trial data (Estruch et al., 2006; PMID: 16418406) support Mediterranean diets with olive oil and nuts as CRP-lowering dietary patterns.
4. Prioritize sleep duration and quality. Targeting 7–9 hours with consistent sleep timing reduces inflammatory cytokine output. If you suspect sleep architecture problems are involved, understanding whether deep sleep can recover after chronic stress is a useful starting point.
5. Consider targeted nutraceutical support. Omega-3s, curcumin, and certain adaptogenic compounds have demonstrated hs-CRP-lowering effects in randomized trials.
6. Evaluate statin therapy with your physician if hs-CRP remains > 2.0 mg/L with neutral or elevated ApoB after lifestyle optimization. The JUPITER trial specifically validated this indication.

---

What This Means for Your Formula

hs-CRP is one of the biomarkers Ones uses when its AI practitioner analyzes your uploaded lab work to build a personalized capsule formula. The reasoning is straightforward: an elevated hs-CRP tells the system that your formula needs ingredients with clinically demonstrated anti-inflammatory activity, not just general wellness support.

Three ingredients in the Ones catalog are particularly relevant when hs-CRP is elevated:

• Omega-3 (EPA/DHA): Ones sources a high-concentration EPA/DHA preparation dosed at clinically relevant levels. The evidence base for omega-3 in hs-CRP reduction is among the strongest of any nutraceutical — a 2012 meta-analysis of 68 randomized trials confirmed significant CRP reductions from EPA/DHA supplementation across multiple populations (Calder, Prostaglandins, Leukotrienes and Essential Fatty Acids 2012; PMID: 22317966). If your omega-3 index is low alongside an elevated hs-CRP, Ones would prioritize this in your formula.
• Liver Support (System Blend): Because CRP is synthesized in the liver, hepatic health is directly upstream of CRP production. Ones' proprietary Liver Support blend targets the metabolic-inflammatory interface at the hepatic level — relevant for people whose elevated hs-CRP is driven by metabolic dysfunction or high visceral fat.
• Adrenal Support (System Blend): When cortisol dysregulation is a driver of chronic inflammation — identifiable through cortisol lab testing patterns — Ones may include the Adrenal Support blend to help normalize HPA axis output, which in turn can reduce the inflammatory signaling that sustains elevated hs-CRP.

The exact combination and capsule count in your plan depends on your full biomarker picture, not a single number — which is why hs-CRP is most valuable as part of a broader panel.

---

Key Takeaways

• hs-CRP requires a specific high-sensitivity assay — standard CRP testing misses the range relevant to cardiovascular and metabolic risk; always confirm your lab used the hs-CRP assay (CPT code 86141).
• One elevated reading is not enough. The AHA recommends averaging two readings taken at least two weeks apart, with no acute illness or vigorous exercise before either draw.
• Optimal hs-CRP is below 1.0 mg/L, with values above 3.0 mg/L warranting investigation of metabolic, cardiovascular, or autoimmune causes.
• Pair hs-CRP with ApoB and Omega-3 Index to distinguish vascular-inflammatory risk from metabolic-inflammatory risk — the distinction shapes which interventions to prioritize.
• The most evidence-backed interventions are omega-3 supplementation at therapeutic doses, Mediterranean dietary patterns, weight loss in those with excess visceral fat, and sleep optimization.
• hs-CRP responds well to personalized intervention — understanding the specific driver (insulin resistance, poor omega-3 status, sleep disruption, or hepatic stress) is more productive than generic anti-inflammatory advice.

---

Always consult a qualified healthcare provider before making changes to your medication regimen or interpreting lab results in the context of a specific medical condition. The information in this article is educational and does not constitute medical advice.